Medicare AdvantageCoverageLow impact
MA11.101, Nucleoplasty
Independence Blue Cross·NJ · Neurosurgery, Pain Management·Medical Policy
Effective date
Jan 21, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued MA11.101 effective 01/21/2026, reaffirming that nucleoplasty for intervertebral disc decompression remains experimental/investigational and is NOT covered for Medicare Advantage members. No changes to coverage determination were made; this is a routine policy reissuance communicating the company's continuing non-coverage position.
Action Required
Before 01/21/2026: Billing team must ensure that claims for nucleoplasty (CPT 22899 for non-lumbar spine, HCPCS S2348 for lumbar spine) submitted to Independence Blue Cross Medicare Advantage plans are flagged as non-covered and denied. Update billing system denial rules and encounter forms to reflect that nucleoplasty is considered experimental/investigational and ineligible for reimbursement. Ensure front-line staff and providers are aware that patient notification of non-coverage must occur before service delivery to avoid balance billing liability. No appeals of nucleoplasty denials will be overturned.